Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Bordeaux
Clinical trial register · France

Clinical Trials in Bordeaux, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9731 matching records held by the registry are in this view. Synced 02 Nov 2026, 03:18 UTC
9731
Studies in scope
all four open statuses
6052
Recruiting now
open to new participants
1028
Lead sponsors
across recruiting studies
Top sites
Villejuif 59 Bordeaux 20 Paris 19 Lyon 17 Angers 12
Narrow the registerReset
Recruitment status
Phase
Site location
Villejuif59 Bordeaux20 Paris19 Lyon17 Angers12
All 63 locations
Target enrolment
to

Trials with a site in Bordeaux

20 of 9731 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
NCT07871864Osteosarcoma, Pediatric Osteosarcoma, Osteosarcoma in Children, Osteosarcoma in Adolescents and Young Adults
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
530
Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Dijon, Grenoble
2026-10-07
Not yet open
Carboplatin-Enhanced Therapy in BRCA-Mutated or Neuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate Cancer
NCT07591467BRCA-Mutated, Neuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate Cancer, Prostate Cancer
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
330
Bordeaux, Lyon, Marseille, Nancy, Villejuif
2026-09
Not yet open
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
24
Villejuif, Bordeaux
2026-07
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
60
Villejuif, Bordeaux, Dijon, Marseille, Paris, Saint-Herblain, Vandœuvre-lès-Nancy
2026-03-25
Recruiting
Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors.
NCT07303387Solid Tumor Malignancies, Clear Cell Endometrial Carcinoma, Ovarian Cancer
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
900
Villejuif, Bordeaux, Lyon, Paris
2026-03-05
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
40
Bordeaux, Nice, Villejuif
2025-07-02
Recruiting
CARE1 Pragmatic Clinical Trial
NCT06364631Metastatic Kidney Cancer, Metastatic Kidney Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
1,250
Angers, Avignon, Bayonne, Besançon, Bordeaux, Caen, Chalon-sur-Saône, Clermont-Ferrand
2024-04-12
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
387
Angers, Bayonne, Bordeaux, Brest, Clermont-Ferrand, Grenoble, Lille, Limoges
2023-10-17
Active, closed
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1
23
Bordeaux, Lille, Lyon, Paris, Villejuif
2023-06-16
Recruiting
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
NCT05476939Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant, Diffuse Midline Glioma, H3K27-altered
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
433
Villejuif, Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand
2022-09-29
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Not applicable
1,800
Amiens, Paris, Saint-Etienne, Angers, Besançon, Bordeaux, Brest, Caen
2022-09-09
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Not applicable
10,000
Bayonne, Bligny, Bordeaux, Corbeil-Essonnes, Épagny, Grenoble, La Réunion, Melun
2022-06-29
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Not applicable
152
Bordeaux, Lille, Lyon, Paris, Poitiers, Reims, Rennes, Saint-Mandé
2022-01-19
Active, closed
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
200
Bordeaux, Lyon, Villejuif
2021-12-06
Active, closed
Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer
NCT04940325Metastatic Lung Cancer, Advanced Non Small Cell Lung Cancer, Unresectable Non-small Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
100
Bordeaux, Brest, Caen, Créteil, Paris, Pierre-Bénite, Strasbourg, Villejuif
2021-05-12
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Observational
1,150
Villejuif, Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand
2020-04-09
Recruiting
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT04221035High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
800
Villejuif, Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand
2019-11-05
Active, closed
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
45
Paris, Villejuif, Bordeaux, Créteil, Lille, Lyon, Toulouse, Vandœuvre-lès-Nancy
2019-01-02
Active, closed
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
352
Villejuif, Angers, Bordeaux, Bron, Caen, Clermont-Ferrand, Dijon, Haguenau
2018-08-08
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1/2
472
Villejuif, Angers, Bordeaux, Lille, Lyon, Marseille, Nantes, Paris
2016-08-03
Rows per page Showing 1–20 of 20
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 2 November 2026. https://priyalifescience.com/clinical-trials-france/city/bordeaux

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,731 studies in total at the last sync on 02 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 20 of those studies with a site in Bordeaux that also match the filters currently applied.

How many clinical trials are recruiting in Bordeaux?

13 of the 20 studies on this page are recruiting new participants as of the 02 Nov 2026, 03:18 UTC sync. A further 2 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bordeaux), 20 studies
PhaseStudiesRecruitingShare
Phase 27335%
Phase 37535%
Not applicable3315%
Observational115%
Phase 1105%
Phase 1/2115%

Most active sponsors

Lead sponsors with the most studies (Bordeaux)
Lead sponsorStudiesRecruiting
Gustave Roussy, Cancer Campus, Grand Paris2013
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.